Mediators and cytokines in persistent allergic rhinitis and nonallergic rhinitis with eosinophilia syndrome

International Archives of Allergy and Immunology

Volumn 159, Issue 2, 2012, Pages 171-178

  Grger, Moritz ^a,d   Klemens, Christine ^a   Wendt, Sebastian ^a   Becker, Sven ^a   Canis, Martin ^b   Havel, Miriam ^a   Pfrogner, Elisabeth ^a   Rasp, Gerd ^c   Kramer, Matthias F ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Allergic rhinitis; Eosinophil cationic protein; Eosinophilia syndrome; Granulocyte macrophage colony stimulating factor; Interleukin 17; Interleukin 5; Tryptase

Indexed keywords

CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL MIGRATION; CELL SURVIVAL; COMPARATIVE STUDY; DERMATOPHAGOIDES; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; NONALLERGIC RHINITIS WITH EOSINOPHILIA SYNDROME; NOSE SECRETION; PERENNIAL RHINITIS; PRIORITY JOURNAL; RHINITIS;

ADOLESCENT; ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CYTOKINES; DERMATOPHAGOIDES PTERONYSSINUS; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MAST CELLS; MIDDLE AGED; NASAL MUCOSA; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; SYNDROME; YOUNG ADULT;

EID: 84861588148     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000336169     Document Type: Article

References (40)

1. van Rijswijk JB, Blom HM, Fokkens WJ: Idiopathic rhinitis, the ongoing quest. Allergy 2005; 60: 1471-1481.
2. Bousquet J, van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147-S334.
3. Nathan RA, Meltzer EO, Derebery J, Campbell UB, Stang PE, Corrao MA, Allen G, Stanford R: The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 2008; 29: 600-608.
4. Naclerio RM, Baroody F: Understanding the inflammatory processes in upper allergic airway disease and asthma. J Allergy Clin Immunol 1998; 101:S345-S351.
5. Frieri M: Inflammatory issues in allergic rhinitis and asthma. Allergy Asthma Proc 2005; 26: 163-169.
6. Crobach M, Hermans J, Kaptein A, Ridderikhoff J, Mulder J: Nasal smear eosinophilia for the diagnosis of allergic rhinitis and eosinophilic non-allergic rhinitis. Scand J Prim Health Care 1996; 14: 116-121.
7. Moneret-Vautrin DA, Jankowski R, Bene MC, Kanny G, Hsieh V, Faure G, Wayoff M: NARES: a model of inflammation caused by activated eosinophils? Rhinology 1992; 30: 161-168.
8. Powe DG, Groot KT, Sisson M, Blokhuis BJ, Kramer MF, Jones NS, Redegeld FA: Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis. J Allergy Clin Immunol 2010; 125: 139-145.
9. Powe DG, Huskisson RS, Carney AS, Jenkins D, Jones NS: Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001; 31: 864-872.
10. Vignali DA: Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243: 243-255.
11. Klimek L, Rasp G: Norm values for eosinophil cationic protein in nasal secretions: influence of specimen collection. Clin Exp Allergy 1999; 29: 367-374.
12. Riechelmann H, Deutschle T, Friemel E, Gross HJ, Bachem M: Biological markers in nasal secretions. Eur Respir J 2003; 21: 600-605.
13. Canakcioglu S, Tahamiler R, Saritzali G, Alimoglu Y, Isildak H, Guvenc MG, Acar GO, Inci E: Evaluation of nasal cytology in subjects with chronic rhinitis: a 7-year study. Am J Otolaryngol 2009; 30: 312-317.
14. Klemens C, Rasp G, Jund F, Hilgert E, Devens C, Pfrogner E, Kramer MF: Mediators and cytokines in allergic and viral-triggered rhinitis. Allergy Asthma Proc 2007; 28: 434-441.
15. Kramer MF, Burow G, Pfrogner E, Rasp G: In vitro diagnosis of chronic nasal inflammation. Clin Exp Allergy 2004; 34: 1086-1092.
16. Segundo GR, Gomes FA, Fernandes KP, Alves R, Silva DA, Taketomi EA: Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments. Biologics 2009; 3: 469-474.
17. Woschnagg C, Rubin J, Venge P: Eosinophil cationic protein (ECP) is processed during secretion. J Immunol 2009; 183: 3949-3954.
18. Rondon C, Fernandez J, Lopez S, Campo P, Dona I, Torres MJ, Mayorga C, Blanca M: Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. J Allergy Clin Immunol 2009; 124: 1005-1011.
19. Wagenmann M, Schumacher L, Bachert C: The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge. Allergy 2005; 60: 1132-1138.
20. Bachert C, Hauser U, Prem B, Rudack C, Ganzer U: Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol 1995; 252(suppl 1):S44-S49.
21. Bachert C, van Kempen M, van Cauwenberge P: Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999; 118: 375-379.
22. Milanese M, Ricca V, Canonica GW, Ciprandi G: Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis. Eur Ann Allergy Clin Immunol 2005; 37: 7-10.
23. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW: Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects: relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994; 150: 1653-1659.
24. Canonica GW, Compalati E: Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol 2009; 158: 260-271.
25. Storms WW: Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy Asthma Immunol 2003; 91: 131-140.
26. Louten J, Boniface K, de Waal MR: Development and function of Th17 cells in health and disease. J Allergy Clin Immunol 2009; 123: 1004-1011.
27. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108: 430-438.
28. Oboki K, Ohno T, Saito H, Nakae S: Th17 and allergy. Allergol Int 2008; 57: 121-134.
29. Hellgren J, Toren K: Nonallergic occupational rhinitis. Clin Allergy Immunol 2007; 19: 241-248.
30. Shusterman D: Environmental nonallergic rhinitis. Clin Allergy Immunol 2007; 19: 249-266.
31. McKinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, Logar A, Henry A, Irvin CG, Piganelli JD, Ray A, Kolls JK: Th17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008; 181: 4089-4097.
32. Wang X, Dong Z, Zhu DD, Guan B: Expression profile of immune-associated genes in nasal polyps. Ann Otol Rhinol Laryngol 2006; 115: 450-456.
33. Molet SM, Hamid QA, Hamilos DL: IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003; 113: 1803-1812.
34. Saitoh T, Kusunoki T, Yao T, Kawano K, Kojima Y, Miyahara K, Onoda J, Yokoi H, Ikeda K: Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma. Int Arch Allergy Immunol 2010; 151: 8-16.
35. Moneret-Vautrin DA, Hsieh V, Wayoff M, Guyot JL, Mouton C, Maria Y: Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 1990; 64: 513-518.
36. Hershey GK: IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 2003; 111: 677-690.
37. Scavuzzo MC, Rocchi V, Fattori B, Ambrogi F, Carpi A, Ruffoli R, Manganelli S, Iannessi F: Cytokine secretion in nasal mucus of normal subjects and patients with allergic rhinitis. Biomed Pharmacother 2003; 57: 366-371.
38. Ciprandi G, Vizzaccaro A, Cirillo I, Tosca M, Massolo A, Passalacqua G: Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis. Int Arch Allergy Immunol 2005; 136: 266-272.
39. Bachert C, Wagenmann M, Hauser U, Rudack C: IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997; 99: 837-842.
40. Egan RW, Umland SP, Cuss FM, Chapman RW: Biology of interleukin-5 and its relevance to allergic disease. Allergy 1996; 51: 71-81.